Cymbalta and Proteus infection - a phase IV clinical study of FDA data

Summary:

Proteus infection is reported as a side effect among people who take Cymbalta (duloxetine hydrochloride), especially for people who are female, 40-49 old, also take Lyrica, and have Bronchitis.

The phase IV clinical study analyzes which people have Proteus infection when taking Cymbalta. It is created by eHealthMe based on reports of 145,249 people who have side effects when taking Cymbalta from the FDA, and is updated regularly.

What is Cymbalta?

Cymbalta has active ingredients of duloxetine hydrochloride. It is often used in depression. eHealthMe is studying from 154,974 Cymbalta users. Check the latest studies of Cymbalta.

What is Proteus infection?

Proteus infection (proteus can cause urinary tract infections) is found to be associated with 189 drugs and 341 conditions by eHealthMe. Check the latest studies of Proteus infection.

On Aug, 07, 2026

145,249 people reported to have side effects when taking Cymbalta.
Among them, 15 people (0.01%) have Proteus infection.

Among these 15 people:

What is the gender of people who have Proteus infection when taking Cymbalta? *

female: 86.67 %
male: 13.33 %

What is the age of people who have Proteus infection when taking Cymbalta? *

What are other drugs people take besides Cymbalta? *

What are other side effects people have besides Proteus infection? *

Pneumonia: 8 people, 53.33%
High Blood Pressure: 8 people, 53.33%
The Flu (the flu is caused by an influenza virus): 8 people, 53.33%
Vitamin B12 Deficiency: 7 people, 46.67%
Gastrointestinal Pain: 7 people, 46.67%
Genital Herpes (herpes infection of genital): 7 people, 46.67%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 7 people, 46.67%
Urinary Tract Infection Bacterial: 7 people, 46.67%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 46.67%
Indigestion: 7 people, 46.67%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 46.67%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 7 people, 46.67%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 7 people, 46.67%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 26.67%
Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 3 people, 20.00%
Type 2 Diabetes: 1 person, 6.67%
Lambert-Eaton Syndrome (this means your immune system mistakenly targets healthy cells and tissues in the body): 1 person, 6.67%
Gait Disturbance: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Cymbalta and have Proteus infection?

- Check whether Proteus infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cymbalta:

Cymbalta (154,974 reports)

Browse all side effects of Cymbalta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Proteus infection:

Proteus infection (189 drugs)

Browse all the conditions that are associated with Proteus infection:

Proteus infection (341 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on duloxetine hydrochloride (the active ingredients of Cymbalta) and Cymbalta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.